טוען...
Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria
Polymyxin B and colistin are currently used as a ‘last-line’ treatment for multidrug-resistant Gram-negative bacteria. However very little is known about the pharmacological differences between polymyxin B(1), polymyxin B(2), colistin A, colistin B, the major cyclic lipopeptides components present i...
שמור ב:
| הוצא לאור ב: | ACS Infect Dis |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4980087/ https://ncbi.nlm.nih.gov/pubmed/27525307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.5b00085 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|